JERSAZE Trademark

Trademark Overview


On Tuesday, January 11, 2011, a trademark application was filed for JERSAZE with the United States Patent and Trademark Office. The USPTO has given the JERSAZE trademark a serial number of 85214751. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 20, 2012. This trademark is owned by Glaxo Group Limited. The JERSAZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jersaze

General Information


Serial Number85214751
Word MarkJERSAZE
Filing DateTuesday, January 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 20, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2011

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Monday, August 20, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 20, 2012ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2012EXTENSION 1 GRANTED
Monday, January 9, 2012EXTENSION 1 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Tuesday, July 19, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2011PUBLISHED FOR OPPOSITION
Monday, April 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 13, 2011ASSIGNED TO LIE
Wednesday, March 30, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2011ASSIGNED TO EXAMINER
Friday, January 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 14, 2011NEW APPLICATION ENTERED IN TRAM